Lightning Round: Goldman Sachs, Chesapeake Energy, Avon and More
Chesapeake Energy : Cramer said he likes CHK over the longer term. But for investors who don’t want to wait, they should consider the preferred shares.
Endo Pharmaceuticals : Cramer is bullish on ENDP.
Goldman Sachs : “I think the analysts are too negative about the stock,” Cramer said. He endorsed GS.
Avon Partners : Cramer thinks AVP, which hasn’t been performing well relative to its peers, will either dump present management or earn itself a takeover bid. “There’s too much long-term value there,” he said. AVP is a buy.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org